SYNTap® Biomarker Test

The SYNTap Test helps physicians diagnose synucleinopathies such as: Parkinson’s, LBD, Alzheimer’s with Lewy Bodies, MCI, and MSA.

This website is intended for the informational purposes of healthcare professionals.

Scientist working at the laboratory

Parkinson’s Disease

How the SYNTap Test helps improve diagnostic accuracy for various types of Parkinson's.

Lewy Body Dementia

How the SYNTap Test can improve the diagnostic challenges of Lewy Body Dementia.

Doctor and patient

AD with Lewy Bodies

How the SYNTap Test helps differentiate the Alzheimer's variant: AD with Lewy Bodies.

Multiple System Atrophy

How the SYNTap Test helps physicians differentiate MSA from Parkinson's disease.

Scientist working with chemicals in laboratory

MCI with Lewy Bodies

How the SYNTap Test helps detect Minimal Cognitive Impairment with Lewy Bodies early.

Download Spec. Sheet

Details on the SYNTap Biomarker Test performance characteristics.

Amprion's scientist, Luis Concha discovering an ultra sensitive prion detection

Explore Our Science

A pioneer of Prion Detection Science®, Amprion innovates biomarker testing to accurately detect misfolded proteins associated with brain diseases.

After decades of research, Amprion is thrilled to rollout its impactful discoveries from the lab to the world. 


Amprion has some important news we need to share with you!

To improve patient access to the SYNTap® biomarker test (CSF), Amprion is reducing the self-pay price for tests with service dates on or after July 1, 2023.

Old self-pay price: $1500.00. New self-pay price: $995.00

Effective July 1, 2023, there is a New ABN (Advanced Beneficiary Notification) form for use when ordering the SYNTap® biomarker test (CSF) for patients on Medicare. Order Process

CPT/PLA – The SYNTap® test has been issued a dedicated PLA code to be used when billing: 0393U
We have applied to be a medicare provider and will soon be able to courtesy bill Medicare for your patients.